Brodalumab Shows Rapid and Sustained Efficacy for Treating Psoriasis Dr Kartikeya Kohli11 July 2023 9:45 AM ISTIn a recent study conducted in Italy, brodalumab, a fully human anti-interleukin (IL)-17 monoclonal antibody, has demonstrated rapid and sustained...
Tildrakizumab linked to improved outcomes in plaque psoriasis patients Jacinthlyn Sylvia10 July 2023 9:30 AM ISTAlmirall, a global biopharmaceutical company specializing in medical dermatology, has announced significant progress in the treatment of...
Pemphigus closely associated with increased prevalence and severity of mood disorders Jacinthlyn Sylvia9 July 2023 11:30 PM ISTA recent study found the increased psychological impact and mood disorders associated to pemphigus, an autoimmune bullous disease. The findings were...
Dersimelagon, an effective oral treatment for patients with erythropoietic protoporphyria: Phase 2 trial Medha Baranwal8 July 2023 9:45 AM ISTUSA: A phase 2 study published in The New England Journal of Medicine claimed that oral dersimelagon may be a safe and effective treatment option for...
acne scars tied with three risk factors: male gender, positive family history of acne, and acne severity Dr. Shravani Dali6 July 2023 8:00 PM ISTThree major risk factors for individuals with acne scars are having a positive family history of acne, being of the male gender, and severity of acne,...
Spesolimab beneficial for prevention of generalized pustular psoriasis flares: Effisayil 2 trial Medha Baranwal6 July 2023 10:00 AM ISTUSA: New late-breaking data from the Effisayil 2 trial revealed an 84% reduction in the risk for generalized pustular psoriasis (GPP) flares with...
Statin use, skin infections, valvular heart disease decreases survival in patients with bullous pemphigoid Medha Baranwal5 July 2023 10:15 AM ISTGermany: A recent study published in the Indian Journal of Dermatology, Venereology and Leprology revealed that skin infections, neurological...
Tralokinumab beneficial for patients with prurigo nodularis-like phenotype atopic dermatitis: JAAD Medha Baranwal4 July 2023 9:15 AM ISTItaly: Tralokinumab, an IL-13 monoclonal antibody, showed clinical improvement in patients with prurigo nodularis-like phenotype atopic dermatitis...
Skin telangiectasias in Systemic sclerosis sine scleroderma associated with diastolic heart dysfunction Dr. Shravani Dali30 Jun 2023 8:00 PM ISTSkin telangiectasias in Systemic sclerosis sine scleroderma associated with diastolic heart dysfunction suggests a new study published in the JAMA...
Topical cinacalcet efficacious in Hailey-Hailey Disease- JAMA study Dr Manoj Kumar Nayak29 Jun 2023 8:00 PM ISTTopical cinacalcet efficacious in Hailey-Hailey Disease- JAMA studyHailey-Hailey disease (HHD) is a rare inherited acantholytic disorder secondary to...
FDA approves first oral JAK inhibitor for treatment of alopecia areata in adolescents Medha Baranwal28 Jun 2023 8:00 PM ISTUSA: The US FDA (Food and Drug Administration) has approved ritlecitinib (Litfulo), a Janus kinase (JAK) inhibitor, for adults and adolescents with...
Male pattern hair loss greatly linked with sugar sweetened beverages Niveditha Subramani28 Jun 2023 9:00 AM ISTMale pattern hair loss (MPHL), has become a global public health problem as its progressive and non-scarring form of hair loss, The incidence of MPHL...
